Literature DB >> 81637

In vitro studies on cell-mediated immunity in patients treated with inosiplex for herpes virus infection.

L J Bradshaw, H L Sumner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 81637     DOI： 10.1111/j.1749-6632.1977.tb21950.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Inosiplex for localized herpes zoster in childhood cancer patients: preliminary controlled study.

Authors:  S Feldman; F A Hayes; S Chaudhary; M Ossi
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

2.  Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.

Authors:  K Y Tsang; H H Fudenberg; G M Galbraith; R P Donnelly; L R Bishop; W R Koopmann
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

Review 3.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

4.  Combined therapy with isoprinosine and CO2 laser microsurgery for the treatment of laryngeal papillomatosis.

Authors:  J Elö; Z Máté
Journal:  Arch Otorhinolaryngol       Date:  1988

Review 5.  Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D M Campoli-Richards; E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.